Sirolimus Prolonged Survival After Living Donor Liver Transplantation for HCC Beynd Milan Criteria; Outcome of a Multicenter Prospective Randomized Phase II Trial (ClinicalTrials. gov Identifier: NCT01374750)-MedSci.cn

Sirolimus Prolonged Survival After Living Donor Liver Transplantation for HCC Beynd Milan Criteria; Outcome of a Multicenter Prospective Randomized Phase II Trial (ClinicalTrials. gov Identifier: NCT01374750)

Lee, KW; Kim, SH; Yi, NJ; Hong, SK; Yoon, G; Kim, H; Oh, D; Han, SS; Park, SJ; Suh, KS

AMERICAN JOURNAL OF TRANSPLANTATION, 2017; 17 ( ): 215

科室
- - 订阅+
  - 更多科室
工具
服务